Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Single Tissue Sample Reveals Breast Cancer Spread

By HospiMedica staff writers
Posted on 14 Feb 2007
A single tissue sample revealed if breast cancer has spread. More...
That means the most aggressive cancer types can be detected at an early stage.

A new method makes it possible to detect the most aggressive types of breast cancer far earlier than previously. At the same time, women with a 'mild' type could be notified quickly that they are out of danger and not have to carry their fears for months without reason.

Ingrid Gribbestad and colleagues at the MR Centre at The Norwegian University of Science and Technology (NTNU, Trondheim, Norway) have developed a new method which involves looking at the biopsies (breast tissue samples) at the molecular level. Today, we have to study the cancerous tumors in microscopes and observe the dangerous changes with our bare eyes. We operate on the lower level when it comes to size, Dr.Gribbestad said.

The method involves taking a 'fingerprint' of the molecules in the tissue sample. This is the first time that the method has been used for breast cancer. There is no doubt that we are at the top internationally in this area, said Dr. Gribbestad.

Dr. Gribbestad can report something about the behavior of a particular cancerous tumor if she knows the history and the molecules of the tumor in question. That makes it possible, for instance, to establish whether the cancer in this tissue has spread to lymph nodes elsewhere in the body. Another positive aspect is that this 'fingerprint' also indicates whether the patient will respond to the medical treatment we initiate, Dr. Gribbestad explained.

That makes it possible to find the patients who should be given chemotherapy even before the operation. In addition, cases where it is safe to remove only the affected tissue instead of the entire breast will be easier to find, meaning that more breasts will be spared.

With this we leave the group treatment for the benefit of individual treatment adapted to each patient's disease profile, concluded Ingrid Gribbestad.



Related Links:
The Norwegian University of Science and Technology

Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Preoperative Skin Preparation
BD ChloraPrep
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.